Judge Robinson denies motion of Sanofi and Regeneron in Praluent/cholesterol case
to overturn an unfavorable verdict.
FiercePharma has some interesting comments, including
Judge Sue Robinson threatened to block Praluent sales unless the parties struck a royalty agreement.
And Robinson has yet to decide whether to halt Praluent sales.
Also, note the piece in Barron's
Regeneron: Who Cares If Amgen Won the Latest Patent Battle?
** Separately, in the realm of the miscellaneous, note the post
Top Patent Partner Accused Of Jumping Out Of Bushes, Groping Jogger